DOCK8 DEFICIENCY

Clinical trials for DOCK8 DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new DOCK8 DEFICIENCY trials appear

Sign up with your email to follow new studies for DOCK8 DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Life-Saving transplant trial offers cure for devastating genetic immune disease

⭐️ CURE ⭐️ Ongoing

This study is testing a stem cell transplant as a potential cure for DOCK8 deficiency, a rare genetic disorder that severely weakens the immune system. The trial is enrolling patients aged 4-35 who have suffered life-threatening infections and have a matched donor. Researchers ar…

Matched conditions: DOCK8 DEFICIENCY

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ CURE ⭐️

Last updated Mar 24, 2026 12:02 UTC

DOCK8 DEFICIENCY

Get alerted when new DOCK8 DEFICIENCY trials appear

Life-Saving transplant trial offers cure for devastating genetic immune disease